Joint with: Immune Cell Therapies: Advances in Cancer and Autoimmune Disease
Cancer Immunotherapy: Clinical Lessons to New Modalities
March 16-19, 2025 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers:
Christian U. Blank, Stefani Spranger and Anna Christina Obenauf
In Person
On Demand
March 16-19, 2025 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers:
Christian U. Blank, Stefani Spranger and Anna Christina Obenauf
Available Formats:
In Person
On Demand
Supported by the Directors' Fund
Available Formats: = In Person = On Demand
Merchandise Options
Registration Options
Booking Function
Sunday, March 16, 2025
Fundraising
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Monday, March 17, 2025
Breakfast
7:00–8:00 AM
Welcome and Keynote Session (Joint)
8:00–9:30 AM
Carl H. June, University of Pennsylvania
Cell Therapies: Current State of the Art
Cell Therapies: Current State of the Art
Ton N. Schumacher, Netherlands Cancer Institute
Dissecting T Cell Recognition of Cancer
Dissecting T Cell Recognition of Cancer
Overcoming Challenges in Immune and Cell Therapy: Insights into Mechanisms of Failure and Solutions (Joint)
9:30–11:30 AM
Coffee Break
9:30–9:50 AM
Nathan Singh, Washington University School of Medicine
Genomic Regulation of CAR T Cell Driven Dysfunction
Genomic Regulation of CAR T Cell Driven Dysfunction
Shannon J. Turley, Genentech, Inc.
CAF Targeting
CAF Targeting
Anna Christina Obenauf, Research Institute of Molecular Pathology
Rational Combination Therapies to Stimulate the APC Compartment
Rational Combination Therapies to Stimulate the APC Compartment
May Daher, MD Anderson Cancer Center
Metabolic Interventions to Enhance Adoptive Cellular Therapies
Metabolic Interventions to Enhance Adoptive Cellular Therapies
Short Talk(s) Chosen from Abstracts
On Own for Lunch
11:30–5:00 PM
Poster Setup
11:30–1:00 PM
Poster Viewing
1:00–10:00 PM
Workshop 1: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
DC and Alternative Immune Cell Activation
5:00–7:00 PM
Matthew F. Krummel, University of California, San Francisco
Immune Archetypes
Immune Archetypes
Stefani Spranger, Massachusetts Institute of Technology
DC Determine Quality of T Cell Responses
DC Determine Quality of T Cell Responses
Nina Bhardwaj, Icahn School of Medicine at Mount Sinai
DC Vaccination in Clinical Trials
DC Vaccination in Clinical Trials
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Tuesday, March 18, 2025
Breakfast
7:00–8:00 AM
Neoadjuvant Cancer Immunotherapy, Where are We Standing
8:00–11:00 AM
Tina Cascone, University of Texas MD Anderson Cancer Center
Neoadjvant Cancer Immunotherapy in NSCLC
Neoadjvant Cancer Immunotherapy in NSCLC
Christian U. Blank, Netherlands Cancer Institute - NKI-AVL
Personalized Neoadjuvant Cancer Immunotherapy in Melanoma
Personalized Neoadjuvant Cancer Immunotherapy in Melanoma
Speaker to be to be Announced
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Poster Setup
11:00–1:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable (Joint)
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Integrative Strategies in Cancer Immunotherapy: Harnessing Myeloid Cells, NK Cells, Unconventional T Cells and More
5:00–7:00 PM
Susan M. Kaech, The Salk Institute
Metabolic Control of Anti-Tumor Immunity
Metabolic Control of Anti-Tumor Immunity
Wolfgang Karl Kastenmueller, Universität Würzburg
Unconventional Innate T Cells
Unconventional Innate T Cells
Ann F. Cheung, Dragonfly Therapeutics
NK Cell Therapeutics
NK Cell Therapeutics
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, March 19, 2025
Breakfast
7:00–8:00 AM
Cytokine/Chemokine Biology and Engineering
8:00–11:00 AM
Jamie Spangler, Johns Hopkins University
Cytokine Engineering
Cytokine Engineering
Joanna R. Groom, Walter and Eliza Hall Institute of Medical Research
Chemokine Signaling and Positioning in the LN
Chemokine Signaling and Positioning in the LN
Howard L. Kaufman, Massachusetts General Hospital and Ankyra Therapeutics
Anchored Cytokines for the Treatment of Cancer
Anchored Cytokines for the Treatment of Cancer
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Workshop 2: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Engineering in Cancer Immunotherapy to Enhance Efficacy (Joint)
5:00–6:45 PM
Jaehyuk Choi, Northwestern University
Talk Title to be Announced
Talk Title to be Announced
Rosandra Natasha Kaplan, NCI, National Institutes of Health
Engineering of Myeloid Cells
Engineering of Myeloid Cells
Julia Carnevale, University of California, San Francisco
CRISPR-Based T Cell Editing to Enhance Cell Therapy
CRISPR-Based T Cell Editing to Enhance Cell Therapy
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Thursday, March 20, 2025
Departure
12:00–11:59 PM
Subscribe for Updates